USPTO grants Vermillion Alzheimer’s infirmity biomarker prominent
Vermillion, Inc. (Pink Sheets: VRML), a molecular diagnostics assembly, today announced that the Of like mind States Letters patent and Trademark Part (USPTO) has issued a perception of pension of a prominent entitled "Biomarkers in the direction of Alzheimer’s disease" to the Entourage. The trade mark claims are directed to biomarker combinations instead of the diagnosis and stewardship of Alzheimer’s disorder and to the assessment of the biomarkers not later than a order of methods, including piles spectrometry and immunoassay.
"The granting of our Alzheimer’s diseasebiomarker unmistakable is additional validation of our proposition to genius quality bulwark. We inspection the increasing scope of our permit portfolio as a pithy corporate asset," said Gail S. Send for, CEO and Chairperson.
CREATOR Vermillion, Inc.
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
